Direct comparison of the A to Z and PROVE IT trials: a second chance to gain a first impression.
作者信息
Brown B Greg
出版信息
Circulation. 2006 Mar 21;113(11):1382-4. doi: 10.1161/CIRCULATIONAHA.106.612374.
Abstract
摘要
相似文献
1
Direct comparison of the A to Z and PROVE IT trials: a second chance to gain a first impression.
Circulation. 2006 Mar 21;113(11):1382-4. doi: 10.1161/CIRCULATIONAHA.106.612374.
2
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Circulation. 2006 Mar 21;113(11):1406-14. doi: 10.1161/CIRCULATIONAHA.105.586347. Epub 2006 Mar 13.
3
4
[LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
MMW Fortschr Med. 2003 Dec 11;145(50):46-9.
5
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006.
6
[For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med. 2006 Jun 15;148(24):6.
7
Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Am Heart J. 2006 Feb;151(2):273-81. doi: 10.1016/j.ahj.2005.04.003.
8
[First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
MMW Fortschr Med. 2003 Dec 18;145(51-52):38.
9
Intensive versus moderate lipid lowering with statins in acute coronary syndromes.
Curr Atheroscler Rep. 2005 Mar;7(2):85-6.
10
Cholesterol limbo: How low should the bar go. Ratcheting down LDL to extra-low levels with high-dose statins seems to work wonders.
Harv Health Lett. 2004 May;29(7):1-2.
Zotero 插件